Table 3.

AHR for all-cause death by facility prevalence of PNVa

Facility Prevalence of PNVAHRb95% CIP
Per 20% more patients having 2 to 4 PNVs0.970.88 to 1.080.620
Per 20% more patients having ≥5 PNVs0.910.83 to 0.990.048
  • a A visit to a nephrologist at least one month before the initiation of HD was regarded as PNV. Restricted to facilities that had at least five patients with PNV information (359 facilities, n = 3774). AHR, adjusted hazard ratio

  • b Compared with having one or no PNVs.